Autologous Cell Therapy

Clinical Data Published on Autologous Cell Therapy for Skin Rejuvenation

Autologous cell therapy shows promise

Clinical data from a randomized, placebo-controlled, Phase-I study published on September 11, 2019 in Skin Pharmacology and Physiology revealed that RCS-01, an autologous cell therapy, is well tolerated and might reverse the effects of aging skin through a gene expression response consistent with an improvement of extracellular matrix (ECM) homeostasis.